{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["osteoarthritis", "oxidative stress", "ozone", "rheumatoid arthritis"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "38543177", "DateRevised": {"Year": "2024", "Month": "03", "Day": "30"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2024", "Month": "03", "Day": "19"}], "ELocationID": ["391", "10.3390/ph17030391"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "17", "Issue": "3", "PubDate": {"Year": "2024", "Month": "Mar", "Day": "19"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Medical Ozone: A Redox Regulator with Selectivity for Rheumatoid Arthritis Patients.", "Abstract": {"AbstractText": ["Rheumatoid arthritis (RA) and osteoarthritis (OA) are the most common arthritic diseases. Medical ozone has demonstrated its effectiveness in combination therapy with methotrexate or non-steroidal anti-inflammatory drugs for RA and OA, respectively. Although RA and OA have been compared from different points of view, few studies have considered their redox status in spite of the oxidative processes that are involved in both diseases. The aim of this study was to compare RA with OA, evaluating their redox status and the effects of ozone on their clinical response to combined therapy with ozone. The redox status of 80 patients was determined: antioxidant defenses, injury markers, two subjective variables (pain and disability), and levels of antibodies against cyclic citrullinated peptides were evaluated. Oxidative stress and clinical response to combined therapy with ozone was higher than in the case of RA. After medical ozone treatment, there was an increase in antioxidant defense and a decrease in injury markers as well as pain, disability, and autoantibody concentrations. Redox biomarkers were able to differentiate between both arthritic diseases and combined therapy with ozone (methotrexate + ozone), showing a therapeutic selectivity for RA in comparison with OA."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy and Food Institute, University of Havana, Havana 13603, Cuba."}], "LastName": "Le\u00f3n Fern\u00e1ndez", "ForeName": "Olga Sonia", "Initials": "OS"}, {"Identifier": ["0000-0003-0605-4838"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy and Food Institute, University of Havana, Havana 13603, Cuba."}], "LastName": "Oru", "ForeName": "Gabriel Takon", "Initials": "GT"}, {"Identifier": ["0000-0003-0328-016X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Society for the Use of Ozone in Prevention and Therapy, D-76473 Iffezheim, Germany."}], "LastName": "Viebahn-Haensler", "ForeName": "Renate", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Rheumatology, Ministry of Public Health, Havana 19210, Cuba."}], "LastName": "L\u00f3pez Cabreja", "ForeName": "Gilberto", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Rheumatology, Ministry of Public Health, Havana 19210, Cuba."}], "LastName": "Serrano Espinosa", "ForeName": "Irainis", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Laboratory of the Surgical and Clinical Teaching Hospital \"10 de Octubre\", Faculty of Medical Sciences, Ministry of Public Health, Havana 19210, Cuba."}], "LastName": "Corrales V\u00e1zquez", "ForeName": "Mar\u00eda Elena", "Initials": "ME"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1789\u20131858. doi: 10.1016/S0140-6736(18)32279-7.", "ArticleIdList": ["10.1016/S0140-6736(18)32279-7", "PMC6227754", "30496104"]}, {"Citation": "Myasoedova E., Crowson C.S., Turesson C., Gabriel S.E., Matteson E.L. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995\u20132007 versus 1985\u20131994: A population-based study. J. Rheumatol. 2011;38:983\u2013989. doi: 10.3899/jrheum.101133.", "ArticleIdList": ["10.3899/jrheum.101133", "PMC3193155", "21459933"]}, {"Citation": "Hootman J.M., Helmick C.G. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 2006;54:226\u2013229. doi: 10.1002/art.21562.", "ArticleIdList": ["10.1002/art.21562", "16385518"]}, {"Citation": "Kang L., Dai C., Wang L., Pan X. Potential biomarkers that discriminate rheumatoid arthritis and osteoarthritis based on the analysis and validation of datasets. BMC Musculoskelet. Disord. 2022;23:319. doi: 10.1186/s12891-022-05277-x.", "ArticleIdList": ["10.1186/s12891-022-05277-x", "PMC8978354", "35379209"]}, {"Citation": "Kim G.M., Park H., Lee S.Y. Roles of osteoclast-associated receptor in rheumatoid arthritis and osteoarthritis. Jt. Bone Spine. 2022;89:105400. doi: 10.1016/j.jbspin.2022.105400.", "ArticleIdList": ["10.1016/j.jbspin.2022.105400", "35504517"]}, {"Citation": "Guo Q., Wang Y., Xu D., Nossent J., Pavlos N.J., Xu J. Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15. doi: 10.1038/s41413-018-0016-9.", "ArticleIdList": ["10.1038/s41413-018-0016-9", "PMC5920070", "29736302"]}, {"Citation": "Saalfeld W., Mixon A.M., Zelie J., Lydon E.J. Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers. Rheumatol. Ther. 2021;8:1493\u20131517. doi: 10.1007/s40744-021-00365-1.", "ArticleIdList": ["10.1007/s40744-021-00365-1", "PMC8572231", "34519965"]}, {"Citation": "Bullock J., Rizvi S.A., Saleh A.M., Ahmed S.S., Do D.P., Ansari R.A., Ahmed J. Rheumatoid arthritis: A brief overview of the treatment. Med. Princ. Pract. 2018;27:501\u2013507. doi: 10.1159/000493390.", "ArticleIdList": ["10.1159/000493390", "PMC6422329", "30173215"]}, {"Citation": "Katz J.N., Arant K.R., Loeser R.F. Diagnosis and treatment of hip and knee osteoarthritis: A review. JAMA. 2021;325:568\u2013578. doi: 10.1001/jama.2020.22171.", "ArticleIdList": ["10.1001/jama.2020.22171", "PMC8225295", "33560326"]}, {"Citation": "Rodr\u00edguez-Vargas G.-S., Santos-Moreno P., Rubio-Rubio J.-A., Bautista-Ni\u00f1o P.-K., Echeverri D., Guti\u00e9rrez-Casta\u00f1eda L.-D., Sierra-Matamoros F., Navarrete S., Aparicio A., Saenz L., et al. Vascular Age, Metabolic Panel, Cardiovascular Risk and Inflammaging in Patients with Rheumatoid Arthritis Compared with Patients with Osteoarthritis. Front. Cardiovasc. Med. 2022;9:894577. doi: 10.3389/fcvm.2022.894577.", "ArticleIdList": ["10.3389/fcvm.2022.894577", "PMC9295407", "35865390"]}, {"Citation": "Conti V., Corbi G., Costantino M., De Bellis E., Manzo V., Sellitto C., Stefanelli B., Colucci F., Filippelli A. Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics. Biomolecules. 2020;10:1672. doi: 10.3390/biom10121672.", "ArticleIdList": ["10.3390/biom10121672", "PMC7765045", "33327600"]}, {"Citation": "Le\u00f3n O.S., Men\u00e9ndez S., Merino N., Castillo R., Sam S., P\u00e9rez L., Cruz E., Bocci V. Ozone oxidative preconditioning: A protection against cellular damage by free radicals. Mediat. Inflamm. 1998;7:289\u2013294. doi: 10.1080/09629359890983.", "ArticleIdList": ["10.1080/09629359890983", "PMC1781855", "9792340"]}, {"Citation": "Le\u00f3n O.S. Ozone Therapy. Oxidative Condition. Basis for Its Clinical Effectiveness. 1st ed. ODREI; Freudenstadt, Germany: 2014. pp. 1\u2013202."}, {"Citation": "Fern\u00e1ndez O.S.L., Viebahn-Haensler R., Cabreja G.L., Espinosa I.S., Matos Y.H., Roche L.D., Santos B.T., Oru G.T., Vega J.C.P. Medical ozone increases methotrexate clinical response and improves cellular redox balance in patients with rheumatoid arthritis. Eur. J. Pharmacol. 2016;789:313\u2013318. doi: 10.1016/j.ejphar.2016.07.031.", "ArticleIdList": ["10.1016/j.ejphar.2016.07.031", "27450487"]}, {"Citation": "Ackerman I.N., Pratt C., Gorelik A., Liew D. Projected Burden of Osteoarthritis and Rheumatoid Arthritis in Australia: A Population-Level Analysis. Arthritis Care Res. 2018;70:877\u2013883. doi: 10.1002/acr.23414.", "ArticleIdList": ["10.1002/acr.23414", "28898565"]}, {"Citation": "Eldjoudi D.A., Barreal A.C., Gonzalez-Rodr\u00edguez M., Ruiz-Fern\u00e1ndez C., Farrag Y., Farrag M., Lago F., Capuozzo M., Gonzalez-Gay M.A., Varela A.M., et al. Leptin in Osteoarthritis and Rheumatoid Arthritis: Player or Bystander? Int. J. Mol. Sci. 2022;23:2859. doi: 10.3390/ijms23052859.", "ArticleIdList": ["10.3390/ijms23052859", "PMC8911522", "35270000"]}, {"Citation": "Pulik \u0141., \u0141\u0119gosz P., Motyl G. Matrix metalloproteinases in rheumatoid arthritis and osteoarthritis: A state of the art review. Rheumatology. 2023;61:191\u2013201. doi: 10.5114/reum/168503.", "ArticleIdList": ["10.5114/reum/168503", "PMC10373173", "37522140"]}, {"Citation": "Sohn R., Junker M., Meurer A., Zaucke F., Straub R.H., Jenei-Lanzl Z. Anti-Inflammatory Effects of Endogenously Released Adenosine in Synovial Cells of Osteoarthritis and Rheumatoid Arthritis Patients. Int. J. Mol. Sci. 2021;22:8956. doi: 10.3390/ijms22168956.", "ArticleIdList": ["10.3390/ijms22168956", "PMC8396606", "34445661"]}, {"Citation": "Thiele G.M., Duryee M.J., Hunter C.D., England B.R., Fletcher B.S., Daubach E.C., Pospisil T.P., Klassen L.W., Mikuls T.R. Immunogenic and Inflammatory Responses to Citrullinated Proteins Are Enhanced Following Modification with Malondialdehyde-Acetaldehyde Adducts. Int. Immunopharmacol. 2020;83:106433. doi: 10.1016/j.intimp.2020.106433.", "ArticleIdList": ["10.1016/j.intimp.2020.106433", "PMC7250734", "32224441"]}, {"Citation": "Ndrepepa G., Kastrati A. Gamma-glutamyl transferase and cardiovascular disease. Ann. Transl. Med. 2016;4:481. doi: 10.21037/atm.2016.12.27.", "ArticleIdList": ["10.21037/atm.2016.12.27", "PMC5233492", "28149843"]}, {"Citation": "Ballatori N., Krance S.M., Notenboom S., Shi S., Tieu K., Hammond C.L. Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 2009;390:191\u2013214. doi: 10.1515/BC.2009.033.", "ArticleIdList": ["10.1515/BC.2009.033", "PMC2756154", "19166318"]}, {"Citation": "Pasquini S., Contri C., Borea P.A., Vincenzi F., Varani K. Adenosine and Inflammation: Here, There and Everywhere. Int. J. Mol. Sci. 2021;22:7685. doi: 10.3390/ijms22147685.", "ArticleIdList": ["10.3390/ijms22147685", "PMC8304851", "34299305"]}, {"Citation": "Brigelius-Floh\u00e9 R., Floh\u00e9 L. Basic Principles and Emerging Concepts in the Redox Control of Transcription Factors. Antioxid. Redox Signal. 2011;15:2335\u20132381. doi: 10.1089/ars.2010.3534.", "ArticleIdList": ["10.1089/ars.2010.3534", "PMC3166203", "21194351"]}, {"Citation": "Le\u00f3n Fern\u00e1ndez O.S., Ajamieh H.H., Berlanga J., Menendez S., Viebahn-H\u00e1nsler R., Re L., Carmona A.M. Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/ reperfusion. Tansplantation. 2008;21:39\u201348.", "ArticleIdList": ["17927680"]}, {"Citation": "Gali\u00e8 M., Covi V., Tabaracci G., Malatesta M. The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure. Int. J. Mol. Sci. 2019;20:4009. doi: 10.3390/ijms20164009.", "ArticleIdList": ["10.3390/ijms20164009", "PMC6720777", "31426459"]}, {"Citation": "Vaillant J.D., Fraga A., D\u00edaz M.T., Mallok A., Viebahn-H\u00e4nsler R., Fahmy Z., Barber\u00e1 A., Delgado L., Men\u00e9ndez S., Fern\u00e1ndez O.S.L. Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats. Eur. J. Pharmacol. 2013;714:318\u2013324. doi: 10.1016/j.ejphar.2013.07.034.", "ArticleIdList": ["10.1016/j.ejphar.2013.07.034", "23911887"]}, {"Citation": "Hao W.T., Huang L., Pan W., Le Ren Y. Antioxidant glutathione inhibits inflammation in synovial fibroblasts via PTEN/PI3K/AKT pathway: An in vitro study. Arch. Rheumatol. 2022;37:212\u2013222. doi: 10.46497/archrheumatol.2022.9109.", "ArticleIdList": ["10.46497/archrheumatol.2022.9109", "PMC9377173", "36017213"]}, {"Citation": "Viebahn-Haensler R., Fern\u00e1ndez O.S.L. Ozone in Medicine. The Low-Dose Ozone Concept and Its Basic Biochemical Mechanisms of Action in Chronic Inflammatory Diseases. Int. J. Mol. Sci. 2021;22:7890. doi: 10.3390/ijms22157890.", "ArticleIdList": ["10.3390/ijms22157890", "PMC8346137", "34360655"]}, {"Citation": "Oru G.T., Viebhan-Haensler R., Cabreja G.L., Espinosa I.S., Santos B.T., Vega J.C.P., Cintas S.S., Fern\u00e1ndez O.S.L. Medical Ozone Reduces the Risk of \u03b3-Glutamyl Transferase and Alkaline Phosphatase Abnormalities and Oxidative Stress in Rheumatoid Arthritis Patients Treated with Methotrexate. SM J. Arthritis Res. 2017;1:1004. doi: 10.36876/smjar.1004.", "ArticleIdList": ["10.36876/smjar.1004"]}, {"Citation": "Fernandez O.S.L., Oru G.T., Vega J.C.P., Fernandez E.G., Viebahn-H\u00e4nsler R., Torres-Carballeira R., Cabreja G.L., Mendez R.M. Ozone + Arthroscopy: Improved Redox Status, Function and Surgical Outcome in Knee Osteoarthritis Patients. Int. J. Innov. Surg. 2020;3:1011."}, {"Citation": "Zhang H., Liu H., Iles K.E., Liu R.-M., Postlethwait E.M., Laperche Y., Forman H.J. 4-Hydroxynonenal Induces Rat \u03b3-Glutamyl Transpeptidase through Mitogen-Activated Protein Kinase\u2013Mediated Electrophile Response Element/Nuclear Factor Erythroid 2\u2013Related Factor 2 Signaling. Am. J. Respir. Cell Mol. Biol. 2006;34:174\u2013181. doi: 10.1165/rcmb.2005-0280OC.", "ArticleIdList": ["10.1165/rcmb.2005-0280OC", "PMC2696200", "16195535"]}, {"Citation": "Liao W., Yang Y., Yang H., Qu Y., Song H., Li Q. Circulating gamma-glutamyl transpeptidase and risk of pancreatic cancer: A prospective cohort study in the UK Biobank. Cancer Med. 2023;12:7877\u20137887. doi: 10.1002/cam4.5556.", "ArticleIdList": ["10.1002/cam4.5556", "PMC10134379", "36583230"]}, {"Citation": "Lee Y., Seo J.H. Potential Causal Association between Elevated Gamma-Glutamyl Transferase Level and Stroke: A Two-Sample Mendelian Randomization Study. Biomolecules. 2023;13:1592. doi: 10.3390/biom13111592.", "ArticleIdList": ["10.3390/biom13111592", "PMC10669367", "38002274"]}, {"Citation": "Kim D., Kim J.H., Lee H., Hong I., Chang Y., Song T.-J. Association of gamma-glutamyl transferase variability with risk of osteoporotic fractures: A nationwide cohort study. PLoS ONE. 2023;18:e0277452. doi: 10.1371/journal.pone.0277452.", "ArticleIdList": ["10.1371/journal.pone.0277452", "PMC10237661", "37267386"]}, {"Citation": "Margis R., Dunand C., Teixeira F.K., Margis-Pinheiro M. Glutathione peroxidase family\u2014An evolutionary overview. FEBS J. 2008;275:3959\u20133970. doi: 10.1111/j.1742-4658.2008.06542.x.", "ArticleIdList": ["10.1111/j.1742-4658.2008.06542.x", "18616466"]}, {"Citation": "Kondo N., Kanai T., Okada M. Rheumatoid Arthritis and Reactive Oxygen Species: A Review. Curr. Issues Mol. Biol. 2023;45:3000\u20133015. doi: 10.3390/cimb45040197.", "ArticleIdList": ["10.3390/cimb45040197", "PMC10137217", "37185721"]}, {"Citation": "Mishra R., Singh A., Chandra V., Negi M.P.S., Tripathy B.C., Prakash J., Gupta V. A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis. Rheumatol. Int. 2012;32:2377\u20132382. doi: 10.1007/s00296-011-1964-1.", "ArticleIdList": ["10.1007/s00296-011-1964-1", "21644045"]}, {"Citation": "Peralta C., Xaus C., Bartrons R., Leon O., Gelpi E., Rosell\u00f3-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free. Radic. Res. 2000;33:595\u2013605. doi: 10.1080/10715760000301121.", "ArticleIdList": ["10.1080/10715760000301121", "11200091"]}, {"Citation": "Effendi W.I., Nagano T., Kobayashi K., Nishimura Y. Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases. Cells. 2020;9:785. doi: 10.3390/cells9030785.", "ArticleIdList": ["10.3390/cells9030785", "PMC7140859", "32213945"]}, {"Citation": "Ajamieh H.H., Berlanga J., Merino N., Sanchez G.M., Carmona A.M., Cepero S.M., Giuliani A., Re L., Leon O.S. Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Transpl. Int. 2005;18:604\u2013612. doi: 10.1111/j.1432-2277.2005.00101.x.", "ArticleIdList": ["10.1111/j.1432-2277.2005.00101.x", "15819811"]}, {"Citation": "Oru G.T., Viebhan-Haensler R., Matos Y.H., D\u00edaz D., Rodr\u00edguez M.C.O., Fern\u00e1ndez O.S.L. Medical ozone prevents inflammatory effects from carrageenan-induced knee joint synovitis in rats through A1 adenosine receptor, as well as lipid and protein oxidative damages. J. Sci. Res. Stud. 2018;5:65\u201372."}, {"Citation": "Mallok A., Vaillant J.D., Soto M.T.D., Viebahn-H\u00e4nsler R., Viart M.d.L.A.B., P\u00e9rez A.F., Cede\u00f1o R.I.D., Fern\u00e1ndez O.S.L. Ozone protective effects against PTZ-induced generalized seizures are mediated by reestablishment of cellular redox balance and A1adenosine receptors. Neurol. Res. 2015;3:204\u2013210. doi: 10.1179/1743132814Y.0000000445.", "ArticleIdList": ["10.1179/1743132814Y.0000000445", "25258110"]}, {"Citation": "Macedo-J\u00fanior S.J., Nascimento F.P., Luiz-Cerutti M., Santos A.R.S. The role of peripheral adenosine receptors in glutamate-induced pain nociceptive behavior. Purinergic Signal. 2021;17:303\u2013312. doi: 10.1007/s11302-021-09781-y.", "ArticleIdList": ["10.1007/s11302-021-09781-y", "PMC8155170", "33860899"]}, {"Citation": "Vincenzi F., Pasquini S., Borea P.A., Varani K. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain. Int. J. Mol. Sci. 2020;21:871. doi: 10.3390/ijms21228710.", "ArticleIdList": ["10.3390/ijms21228710", "PMC7698931", "33218074"]}, {"Citation": "Declaration of Helsinki, 2013, 7th Revisi\u00f3n.  [(accessed on 20 September 2005)].  Available online:  http://jama.md/H1WvEO."}, {"Citation": "Wichmann B.A., Hill I.D. Algorithm AS 183: An effcient and portable pseudo-random number generator. Appl. Stat. 1982;31:188\u2013190. doi: 10.2307/2347988.", "ArticleIdList": ["10.2307/2347988"]}, {"Citation": "McLeod A.I. Remark AS R58: A Remark on algorithm AS 183. An efficient and portable pseudo-random number generator. J. Appl. Stat. 1985;34:198. doi: 10.2307/2347378.", "ArticleIdList": ["10.2307/2347378"]}, {"Citation": "Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., 3rd, Birnbaum N.S., Burmester G.R., Bykerk V.P., Cohen M.D., et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 2010;69:1580\u20131588. doi: 10.1136/ard.2010.138461.", "ArticleIdList": ["10.1136/ard.2010.138461", "20699241"]}, {"Citation": "Cardiel M.H., Abello-Banfi M., Ruiz-Mercado R., Alarcon-Segovia D. How to measure health status in rheumatoid arthritis in non-English speaking patients: Validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI) Clin. Exp. Reum. 1993;11:117\u2013121.", "ArticleIdList": ["8508553"]}, {"Citation": "Merino R.J. Utilidad diagn\u00f3stica de la velocidad de sedimentaci\u00f3n globular. Med. Integral. 2002;39:325\u2013329."}, {"Citation": "Boehringer_Mannheim Biochemica Information. A Revised Biochemical Reference Source. Enzymes for Routine. 1st ed. Boehringer Mannheim; Berlin, Germany: 1987. pp. 80\u201381."}, {"Citation": "Sedlak J., Lindsay R.H. Estimation of total protein-bound and nonprotein sulfhydryl groups in tissue with Ellman\u2019s reagent. Anal. Biochem. 1968;25:192\u2013205. doi: 10.1016/0003-2697(68)90092-4.", "ArticleIdList": ["10.1016/0003-2697(68)90092-4", "4973948"]}], "ReferenceList": []}], "History": [{"Year": "2024", "Month": "1", "Day": "11"}, {"Year": "2024", "Month": "3", "Day": "11"}, {"Year": "2024", "Month": "3", "Day": "12"}, {"Year": "2024", "Month": "3", "Day": "28", "Hour": "6", "Minute": "46"}, {"Year": "2024", "Month": "3", "Day": "28", "Hour": "6", "Minute": "45"}, {"Year": "2024", "Month": "3", "Day": "28", "Hour": "1", "Minute": "23"}, {"Year": "2024", "Month": "3", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["38543177", "PMC10975283", "10.3390/ph17030391", "ph17030391"]}}], "PubmedBookArticle": []}